1. Home
  2. ARQQ vs EOLS Comparison

ARQQ vs EOLS Comparison

Compare ARQQ & EOLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arqit Quantum Inc.

ARQQ

Arqit Quantum Inc.

HOLD

Current Price

$23.63

Market Cap

396.8M

Sector

Technology

ML Signal

HOLD

Logo Evolus Inc.

EOLS

Evolus Inc.

HOLD

Current Price

$4.75

Market Cap

444.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARQQ
EOLS
Founded
2017
2012
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
396.8M
444.0M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
ARQQ
EOLS
Price
$23.63
$4.75
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
6
Target Price
$60.00
$18.80
AVG Volume (30 Days)
311.8K
1.4M
Earning Date
12-09-2025
03-03-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$530,000.00
$285,823,000.00
Revenue This Year
$1,054.72
$14.00
Revenue Next Year
$30.00
$16.78
P/E Ratio
N/A
N/A
Revenue Growth
N/A
15.10
52 Week Low
$11.00
$4.68
52 Week High
$62.00
$17.12

Technical Indicators

Market Signals
Indicator
ARQQ
EOLS
Relative Strength Index (RSI) 39.54 26.55
Support Level $23.22 $4.68
Resistance Level $28.15 $5.10
Average True Range (ATR) 1.74 0.34
MACD -0.16 -0.05
Stochastic Oscillator 14.34 5.51

Price Performance

Historical Comparison
ARQQ
EOLS

About ARQQ Arqit Quantum Inc.

Arqit Quantum Inc is a cybersecurity company that has pioneered a symmetric key agreement technology that makes the communications links of any networked device or data at rest secure against current and future forms of cyber attack - even an attack from a quantum computer. The company delivers its symmetric key agreement technology via its product SKA-Platform. The firm operates in one segment, that is, the provision of cybersecurity services. The company operates and generates its revenue from UK.

About EOLS Evolus Inc.

Evolus Inc is a performance beauty company with a customer-centric approach to delivering breakthrough products in the self-pay aesthetic market. The company's first commercial product is Jeuveau, a proprietary 900 kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe glabellar lines, also known as frown lines, in adults. Its primary market is the cash-pay aesthetic market, which includes medical products purchased by physicians and other customers that are then sold to consumers or used in procedures for aesthetic indications. It generates product revenue from the sale of Jeuveau in the United States and Europe, and service revenue from distribution partners in Canada.

Share on Social Networks: